(Q41907154)

13 October 2017

New somatostatin molecule for management of endocrine tumours (English)

1 reference

13 October 2017

Bonfils S

1

1 reference

PMC publication ID

1432656

13 October 2017

language of work or name

English

0 references

publication date

1 May 1985

1 reference

13 October 2017

1 reference

13 October 2017

26

1 reference

13 October 2017

5

1 reference

13 October 2017

433-437

1 reference

Somatostatinoma syndrome. Clinical, morphological and metabolic features and therapeutic aspects

13 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1432656

Inhibition of gastrin and gastric-acid secretion by growth-hormone release-inhibiting hormone.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1432656

Treatment of patients with pancreatic endocrine tumours using a new long-acting somatostatin analogue symptomatic and peptide responses

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1432656

Effect of somatostatin on intestinal motility

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1432656

Proceedings: Investigation and treatment of a recurrent vipoma

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1432656

Somatostatin Inhibition of Insulin and Gastrin Hypersecretion in Pancreatic Islet-Cell Carcinoma

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1432656

Somatostatin inhibits diarrhea in the carcinoid syndrome.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1432656

Therapeutic value of somatostatin in gastroenterology. Theoretical basis. Practical trends

18 August 2018

1 reference

12 December 2020

Inhibitory Effect of Prolonged Administration of Long-Acting Somatostatin on Gastrin-Stimulated Fundic Epithelial Cell Growth in the Rat

1 reference

12 December 2020

The carcinoid flush. Provocation by pentagastrin and inhibition by somatostatin

1 reference

12 December 2020

Effect of intravenous somatostatin on jejunal absorption of glucose, amino acids, water, and electrolytes

1 reference

12 December 2020

Effect of somatostatin infusion on jejunal water and electrolyte transport in a patient with secretory diarrhea due to malignant carcinoid syndrome

1 reference

12 December 2020

Rapid improvement of skin lesions in glucagonomas with intravenous somatostatin infusion

1 reference

12 December 2020

Evaluation of antisecretory drug therapy of zollinger-ellison syndrome (ZES) using 24-hour pH monitoring

1 reference

12 December 2020

Effect of somatostatin on diarrhea and on small intestinal water and electrolyte transport in a patient with pancreatic cholera

1 reference

12 December 2020

Identifiers

DOI

10.1136/GUT.26.5.433

1 reference

13 October 2017

1 reference

PMC publication ID

1432656

13 October 2017

PubMed publication ID

2860051

1 reference

PMC publication ID

1432656